- Report
- October 2024
- 181 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 510 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- August 2022
- 330 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- January 2024
- 183 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- May 2022
- 167 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- May 2022
- 83 Pages
Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- May 2023
- 92 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Book
- October 2022
- 688 Pages
- Book
- April 2019
- 224 Pages
The Nerve Regeneration market is a subset of the Healthcare Services industry, focusing on the development of treatments and therapies to restore nerve function. This includes treatments for conditions such as spinal cord injury, stroke, and peripheral neuropathy. These treatments can involve the use of stem cells, gene therapy, and other regenerative medicine techniques.
Nerve regeneration is an emerging field of medicine, with the potential to improve the quality of life for those suffering from nerve damage. Research is ongoing to develop new treatments and therapies, and to improve existing ones.
Companies in the Nerve Regeneration market include AxoGen, Inc., Athersys, Inc., and Neuralstem, Inc. These companies are focused on developing treatments and therapies to restore nerve function, and are actively researching new treatments and therapies. Show Less Read more
